The promises of diversity and inclusion in genomics research include novel insights into human biology, advanced clinical care applications that leverage genomic information and improve our understanding of genomic contributions to health outcomes. This discussion draws on two recent publications co-authored by the speaker reporting barriers to diversity and inclusion in genomics research and evidence of progress. Using a lens focused on the ethical, legal, and social implications of genomics research, Shawneequa Callier discusses the growing attention to diversity and inclusion within the context of research participation and leadership and how investigators are overcoming some of the barriers to inclusion. Callier also describes some of the pitfalls of genomics research involving underserved and underrepresented populations from a bioethics perspective.
About the Equity in Biomedicine Seminar Series (EBM)
This video is part of the Equity in Biomedicine Seminar Series (EBM), an institute-wide interactive meeting that focuses on critical issues related to equity and representation in biomedical research, especially as it applies to genomics research and precision medicine. Speakers dive into the equal or unequal social implications of their work: Who is affected? How are they affected? Why? The overall goal of this series is to foster discussions about equity and inspire Broad scientists and trainees to reflect on the social impact of their own research.
The EBM series is sponsored by the IDEA Office; each event in the series is presented by one or more Broad scientific groups in collaboration with Shades@Broad and the organizing committee. For more information about the EBM series or to nominate a future seminar speaker, contact Mireille Kamariza.